Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead Plaintiff Position in the Class Action Lawsuit Against

Glancy Binkow & Goldberg Encourages Investors to Inquire About a Lead
Plaintiff Position in the Class Action Lawsuit Against Incyte Corporation --
INCY

LOS ANGELES, April 19, 2013 (GLOBE NEWSWIRE) -- Glancy Binkow & Goldberg LLP
announces that a class action lawsuit has been filed in the United States
District Court for the District of Delaware on behalf of a class (the "Class")
comprising all purchasers of the common stock of Incyte Corporation ("Incyte"
or the "Company") (Nasdaq:INCY) between April 26, 2012 and August 1, 2012,
inclusive (the "Class Period"). Investors who have losses of $100,000 or more
are encouraged to contact the firm for information concerning a lead plaintiff
position in the class action suit and have until May 6, 2013 to file a motion
with the Court to be appointed as lead plaintiff.

Incyte, a biopharmaceutical company, focuses on the discovery, development and
commercialization of proprietary small molecule drugs for oncology and
treatment of inflammation. The Complaint alleges that Incyte issued misleading
statements concerning demand for the Company's myelofibrosis drug, Jakafi.

On August 2, 2012 Incyte announced the Company's second quarter 2012 financial
results and disclosed that the sales growth of Jakafi had been much softer
during the second quarter of 2012 than investors and certain stock analysts
had been led to expect. In response to these disclosures, the price of Incyte
stock declined 22% from its August 1, 2012 close of $24.92 per share, to close
at $19.57 per share on August 2, 2012 on heavy trading volume.

If you are a member of the Class described above, you may move the Court to
serve as lead plaintiff no later than May 6, 2013; however, you must meet
certain legal requirements. If you wish to learn more about this action or
have any questions concerning this Notice or your rights or interests with
respect to these matters, please contact Michael Goldberg, Esquire, of Glancy
Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles,
California 90067, by telephone at (310) 201-9150 or Toll Free at (888)
773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at
http://www.glancylaw.com.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

CONTACT: Glancy Binkow & Goldberg LLP, Los Angeles, CA
         Michael Goldberg
         (310) 201-9150 or (888) 773-9224
         shareholders@glancylaw.com
         www.glancylaw.com

Company Logo